What is Coral Laboratories Ltd (524506) share price return in the past 10 years?

Coral Laboratories Ltd share price has appreciated 1% annually (CAGR) over the past ten years.

What is the share price of Coral Laboratories Ltd (524506)?

Company share prices are keep on changing according to the market conditions. The current trading price of Coral Laboratories Ltd (524506) on 04-Jun-2026 16:59:59 at 16:59 is 513.25.

What is the P/E ratio of Coral Laboratories?

The latest standalone P/E ratio of Coral Laboratories as of 04-Jun-2026 is 11.19.

What is the P/B ratio of Coral Laboratories Ltd (524506)?

The latest standalone P/B ratio of Coral Laboratories Ltd (524506) as of 04-Jun-2026 is 0.88.

What is the 52-week high and low of Coral Laboratories Ltd (524506)?

The 52-week high of Coral Laboratories Ltd (524506) is Rs. 636.00 and the 52-week low is Rs. 360.00.

Coral Laboratories Ltd (524506) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Coral Laboratories Ltd (524506)
Brand: Coral Laboratories

Coral Laboratories Ltd (524506)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524506 NSE: Pharmaceuticals & Drugs | Small Cap | Coral Laboratories Share Price

Coral Laboratories Ltd (524506)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524506 NSE: Pharmaceuticals & Drugs | Small Cap | Coral Laboratories Share Price

Key Metrics

Valuation Multiples

Market Cap

₹183 Cr.

Current Price

₹513.3

52-Week Low / High

₹360 / 636

TTM EPS

₹45.9

TTM Sales

₹85.9 Cr.

Book Value per Share

₹585.3

P/E Ratio

11.19

In line with its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

0.88

Higher than its 5-year historical median

Price to Sales (P/S)

2.13

Higher than its 5-year historical median

EV/EBITDA

4.59

Lower than its 5-year historical median

Dividend Yield

0.21%

Profitability Efficiency

Return on Equity (ROE)

12.76%

Outperforms industry median

Return on Capital Employed (ROCE)

17.04%

Outperforms industry median

Return on Assets (ROA)

11.10%

Operating Profit Margin

22.8%

Net Profit Margin

21%

Gross Profit Margin

30.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

37.47%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

61.58%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

53.01%

Asset Quality

Promoter Holding

71.51%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹206 Cr.

Equity

₹3.6 Cr.

Face Value

₹10

All Time Low / High

₹7.25 / 1190.00

Coral Laboratories stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Coral Laboratories Ltd a good quality company?

Coral Laboratories Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Coral Laboratories Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Coral Laboratories Ltd vs industry peers?

Coral Laboratories Ltd revenue CAGR is 10.26%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Coral Laboratories Ltd?

Promoters hold 71.51% of the Coral Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Coral Laboratories Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 0.9% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	26.9%	27.2%	15.9%	13.4%	7.9%	13.4%	7.9%	5.4%	12.5%	17%	-
Value Creation Index ⓘ	0.9	1.0	0.1	0.0	-0.4	-0.1	-0.4	-0.6	-0.1	0.2	-
Growth Parameters ⓘ
Sales ⓘ	77	95.5	92.5	91.1	70.6	96.6	75.6	78.1	83.7	115	86
Sales YoY Gr.	-	24%	-3.1%	-1.5%	-22.5%	36.8%	-21.7%	3.3%	7.1%	37.5%	-
Adj EPS ⓘ	32.9	46.2	32.6	25.4	16.6	37.9	22.6	11.6	42.7	66.2	45.9
YoY Gr.	-	40.5%	-29.3%	-22.1%	-34.8%	128.6%	-40.4%	-48.6%	266.7%	55.2%	-
BVPS (₹) ⓘ	196.4	305.5	325.6	318.5	323.8	382.5	436.8	433.3	496.8	563.2	585.3
Adj Net Profit ⓘ	11.7	16.5	11.7	9.1	5.9	13.6	8.1	4.2	15.2	23.7	16
Cash Flow from Ops. ⓘ	5.1	10.8	13.5	-0.9	-3.9	0.9	6.1	12.7	-5.5	-1.2	-
Debt/CF from Ops. ⓘ	0.1	0.2	0.1	-1.6	-1.5	6.7	1	0	0	-2.9	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	4.6%	10.3%	15%	37.5%
Adj EPS ⓘ	8.1%	31.9%	43.1%	55.2%
BVPSⓘ	12.4%	11.7%	8.8%	13.4%
Share Price	1%	2%	30%	-15.5%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	18.2	18.4	10.3	7.9	5.2	10.7	5.5	2.7	9.2	12.5	8
Op. Profit Mgn % ⓘ	21.4	24.4	16.6	13.6	7.7	16.4	10.9	4.9	19.4	22.8	17.7
Net Profit Mgn % ⓘ	15.2	17.3	12.6	10	8.4	14	10.7	5.3	18.2	20.6	19.1
Debt to Equity ⓘ	0	0	0	0	0.1	0.1	0	0	0	0	0
Working Cap Days ⓘ	241	229	243	247	332	273	382	346	301	226	345
Cash Conv. Cycle ⓘ	127	127	140	129	181	146	213	180	120	92	302

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	77	95	92	91	71	97	76	78	84	115
Operating Expenses ⓘ +	61	72	77	79	65	81	67	74	67	89
Manufacturing Costs	22	32	25	28	19	26	21	22	23	25
Material Costs	27	29	36	32	27	32	26	31	22	35
Employee Cost	5	7	9	10	10	10	11	11	11	15
Other Costs ⓘ	7	5	8	9	9	13	10	10	12	14
Operating Profit ⓘ	16	23	15	12	5	16	8	4	16	26
Operating Profit Margin (%)	21.4%	24.4%	16.6%	13.6%	7.7%	16.4%	10.9%	4.9%	19.4%	22.8%
Other Income ⓘ +	3	3	4	5	6	4	5	7	7	9
Exceptional Items ⓘ	0	-0	0	0	0	0	1	0	-0	-1
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	2	2	2	2	2	2	2	2	2	2
Profit Before Tax ⓘ	17	25	18	16	9	18	12	8	21	32
Tax ⓘ	5	8	6	5	2	4	3	2	5	8
Profit After Tax	12	16	12	10	7	14	9	6	16	24
PAT Margin (%)	16.1%	17.1%	13.5%	11.2%	10.1%	14.0%	12.0%	8.3%	18.9%	21.0%
Adjusted EPS (₹)	34.7	45.6	34.8	28.6	20.0	37.9	25.3	18.0	44.2	67.6
Dividend Payout Ratio (%)	8.70%	11%	5.70%	7%	0%	0%	0%	0%	4.50%	2.20%

Valuation of Coral Laboratories - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	70	109	116	114	116	137	156	155	177	201
Share Capital ⓘ	4	4	4	4	4	4	4	4	4	4
Reserves ⓘ	67	106	113	110	112	133	152	151	174	198
Debt +	0	2	2	1	6	6	6	0	0	4
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	2	2	1	6	6	6	0	0	4
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	10	10	13	13	14	15	9	4	13	7
Others Liabilities ⓘ	9	10	9	8	9	10	19	15	15	18
Total Liabilities ⓘ	89	131	140	136	144	168	190	174	206	229
Fixed Assets
Net Fixed Assets ⓘ +	18	18	21	22	22	20	23	24	23	22
Gross Block	34	32	37	39	40	41	46	49	50	51
Accumulated Depreciation	16	14	15	17	19	21	23	25	27	29
CWIP ⓘ	0	0	0	0	0	1	2	0	0	2
Investments ⓘ	5	39	46	29	26	33	46	41	50	52
Inventories	13	21	18	16	19	22	18	13	15	10
Trade Receivables	28	31	32	30	34	39	38	23	28	34
Cash Equivalents ⓘ	9	12	11	23	30	35	37	40	61	80
Others Assets ⓘ	17	10	12	15	13	18	25	32	28	29
Total Assets ⓘ	89	131	140	136	144	168	190	174	206	229

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	5	11	13	-1	-4	1	6	13	-5	-1
PBT ⓘ	17	25	18	16	9	18	11	8	21	33
Adjustment ⓘ	0	0	1	1	1	-0	-0	0	-2	-3
Changes in Working Capital ⓘ	-6	-5	0	-13	-13	-13	-0	6	-20	-24
Tax Paid ⓘ	-5	-9	-6	-5	-1	-3	-4	-2	-5	-7
Cash Flow From Investing Activity ⓘ +	-3	-10	-13	3	-2	-0	-6	-3	1	-0
Capex	-1	-2	-5	-3	-1	-1	-6	-2	-1	-0
Net Investments	-3	-9	-9	5	0	0	-2	-2	0	-0
Others ⓘ	2	1	1	1	-0	1	2	1	2	1
Cash Flow From Financing Activity ⓘ +	-0	0	-3	-1	4	0	0	-6	0	3
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	-0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Dividend Paid ⓘ	0	-1	-2	-1	-1	0	0	0	0	-1
Others ⓘ	0	2	0	-0	4	0	0	-6	0	4
Net Cash Flow ⓘ	2	1	-2	1	-2	1	0	4	-4	1

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	19.18	18.17	11.04	8.88	6.22	10.74	6.18	4.15	9.5	12.76
ROCE (%)	26.93	27.23	15.91	13.44	7.86	13.35	7.87	5.41	12.48	17.04
Asset Turnover Ratio	0.97	0.87	0.68	0.66	0.5	0.62	0.42	0.43	0.44	0.53
PAT to CFO Conversion(x)	0.42	0.69	1.08	-0.1	-0.57	0.07	0.67	2.17	-0.31	-0.04
Working Capital Days
Receivable Days	122.10	111.70	122.90	124.10	167.40	139	186.50	143.80	112.60	98.10
Inventory Days	55.20	65	75.60	67.60	91.70	77.40	96.60	72.10	60.30	39.70
Payable Days	106.80	126	116.40	144.30	181.20	164.80	167.30	75.80	146.80	102.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Coral Laboratories Ltd FAQs

The current trading price of Coral Laboratories on 04-Jun-2026 16:59 is ₹513.2.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Coral Laboratories stood at ₹183.4 Cr

The latest P/E ratio of Coral Laboratories as of 03-Jun-2026 is 11.19.

The latest P/B ratio of Coral Laboratories as of 03-Jun-2026 is 0.88.

The 52-week high of Coral Laboratories is ₹636.0 and the 52-week low is ₹360.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Coral Laboratories is ₹85.90 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Coral Laboratories Ltd is a average quality company.

The key valuation ratios of Coral Laboratories Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Coral Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Coral Laboratories Ltd

Coral Laboratories was founded in 1994. The company is equipped with an ultra modern manufacturing unit in the state of Gujarat, Daman & today is a force to reckon with in the pharmaceutical industry; a fact which has been endorsed by the WHO GMP certification issued by the Food & Drugs Control Administration and ISO 9001-2000 Quality certification issued by American Quality Assessors.

The Company with deep basket of products is focused in hostlic human welfare and is bringing planfort to people with its Inflammatory, Bacterial, Biotic, Protein deficiencies & Skin conditions. Medicines across the nation, manufactured under the ZEST group & MOXBRO group being the most popular brands across the nation, manufactured by the company.Coral Laboratories has been following a steady growth path on the pillars of its philosophy of â€œTotal Quality Managementâ€ & â€œQuality Products at Affordable Pricesâ€.

The state-of-the art manufacturing facilities meet the stringent and over changing quality requirement of the most discerning buyers. Coral has a multi location manufacturing facilities based on Baroda, Daman & Vasai for strategies convenience. The facilities carrying WHO-GMP & ISO 9001 : 2000 certification. The new manufacturing facilities under expansion to have UK â€“ MHRA and USâ€“ FDA certification.

Coral has one of the best quality control laboratory in indian pharmaceuticals industry equipped with latest and sensitive laboratory instruments.

Product range of the company includes:

Capsules & Dry Syrups
Tablets
Liquid Orals
Kits
Ointment & Cream
Injection â€“ Eye â€“ Ear Drops
Others

Achievements/ recognition:

WHO GMP certification issued by the Food & Drugs Control Administration
ISO 9001-2000 Quality certification issued by American Quality Assessors.

Coral Laboratories Ltd (524506)

Coral Laboratories Ltd (524506)

Coral Laboratories stock performance